New Delhi, April 3 -- Shares of Indian pharmaceutical firms with considerable stakes in the US market, including Gland Pharma Ltd, Aurobindo Pharma Ltd, Dr. Reddy's Laboratories Ltd, and Sun Pharma Ltd, experienced an increase of 3%-13% during Thursday's trading session after US President Donald Trump refrained from making specific reciprocal tariff declarations pertaining to the pharmaceutical industry.

Trump unveiled reciprocal tariffs affecting over 60 nations, including India, the European Union, China, and Vietnam, among others.

According to a fact sheet issued by the White House, drugs and various other products, including those already affected by other tariffs, are excluded from the new levies.

However, it's important to highli...